Primary Recipient

UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER AT DALLAS

Amount

$237,750.00

Award Date

7/05/2010

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

While the thiazolidinedione (TZD) drugs are widely used to treat type 2 diabetes, how they work and cause their side effects is not fully understood. Here we will examine how the hormone, FGF21, contributes to the beneficial and harmful effects of TZDs. I